Lung Cancer Clinical Trial
Empathic Communication Skills (ECS) Training
The purpose of this study is to find out if a new training program for cancer care providers called Empathic Communication Training (ECT) will be effective in helping care providers develop or increase the skills needed to provide care that limits lung cancer stigma.
The aims of this study are:
to evaluate the effect of the ECS training on OCP primary outcomes (communication and empathic skill uptake) and secondary outcomes (ECS training appraisal - relevance, novelty, clarity; self-efficacy, empathy, compassion burn-out);
to evaluate the effect of the ECS training vs. WLC on patients' reported primary outcomes (lung cancer stigma), and secondary outcomes (perceived clinician empathy, satisfaction with communication, psychological distress, patients' experience of clinical encounter, and overall patient satisfaction).
Additionally, acceptance of referral to tobacco cessation (for those currently smoking) will be explored; and
to examine potential moderators of OCP (e.g., demographic characteristics, professional role characteristics) and patient outcomes (e.g., demographic characteristics, illness characteristics).
Our central hypothesis is that the ECS training will demonstrate significant short-term improvements in clinicians' uptake of empathic skills and self-efficacy and will be superior to WLC with regards to patient reported measures of stigma, clinician empathy, satisfaction, and overall experience.
Employs at least 15 FTE OCPs (i.e., oncologists, nurse practitioners and physician assistants) as per self report
Reports a clinic volume of at least 20 new lung cancer patients per month as per self report
OCP Participant Eligibility
OCPs who are thoracic oncology physicians (radiologists, medical oncologists, pulmonologists, and surgeons), NPs, or PAs and currently treating lung cancer patients, as per self-report;
OCP conducts consultations with lung cancer patients, as per self-report;
OCP sees at least 1 lung cancer patient per week, as per self-report;
Patient under the care of a participating OCP as per self report;
English and/or Spanish speaking;
In general, which language do you prefer to receive your medical care, English/Spanish/both English and Spanish Equally?
If English, treat as fluent in English, no additional language questions
If Spanish, treat as fluent in Spanish, no additional language questions
If both English and Spanish equally, ask the follow-up questions and go with whichever language is endorsed as best. If endorsed equally, assign to category patient prefers
How well do you speak English? Not at all/ Not well/Well/Very well
How well do you speak Spanish? Not at all/Not well/Well/Very well
Is at least 18 years of age as per self report;
Has a suspicious lung mass or confirmed lung cancer diagnosis, as per clinician judgment or medical record note;
Is a former or current smoking as per self report;
Has had no more than 10 prior visits with the participating OCP, as per the medical record and/or self report
Individuals of impaired decision-making capacity as per a clinician's judgment or as documented in the EMR.
Site and OCP Exclusion
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 6 Locations for this study
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.